Wilmington Savings Fund Society FSB Sells 5,535 Shares of Cigna Group $CI

Wilmington Savings Fund Society FSB lowered its position in Cigna Group (NYSE:CI) by 35.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 10,205 shares of the health services provider’s stock after selling 5,535 shares during the quarter. Wilmington Savings Fund Society FSB’s holdings in Cigna Group were worth $2,942,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Mirae Asset Global Investments Co. Ltd. raised its position in Cigna Group by 11.7% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider’s stock valued at $13,039,000 after purchasing an additional 4,738 shares in the last quarter. Maj Invest Holding A S lifted its position in Cigna Group by 2.4% in the 3rd quarter. Maj Invest Holding A S now owns 422,728 shares of the health services provider’s stock worth $121,854,000 after buying an additional 10,042 shares during the last quarter. Providence Capital Advisors LLC grew its position in Cigna Group by 1,016.8% during the third quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider’s stock valued at $2,453,000 after acquiring an additional 7,748 shares during the last quarter. National Pension Service lifted its holdings in shares of Cigna Group by 3.2% in the 3rd quarter. National Pension Service now owns 683,751 shares of the health services provider’s stock worth $197,091,000 after acquiring an additional 21,203 shares during the last quarter. Finally, SCS Capital Management LLC boosted its stake in shares of Cigna Group by 39.1% in the 2nd quarter. SCS Capital Management LLC now owns 30,633 shares of the health services provider’s stock valued at $10,127,000 after purchasing an additional 8,609 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Insiders Place Their Bets

In other Cigna Group news, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the sale, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. The trade was a 6.60% decrease in their position. The SEC filing for this sale provides additional information. Insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

CI has been the subject of several recent research reports. Guggenheim reissued a “buy” rating and issued a $318.00 price target on shares of Cigna Group in a research note on Monday, February 2nd. Leerink Partners increased their target price on Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a report on Friday, February 6th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Cigna Group in a research report on Monday, December 29th. Jefferies Financial Group increased their price objective on Cigna Group from $310.00 to $333.00 and gave the company a “buy” rating in a research note on Monday, February 9th. Finally, UBS Group restated a “buy” rating and issued a $375.00 target price on shares of Cigna Group in a report on Monday, February 9th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $333.11.

Cigna Group Stock Performance

NYSE:CI opened at $264.87 on Thursday. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. The firm’s fifty day simple moving average is $278.57 and its 200 day simple moving average is $282.09. The stock has a market cap of $69.80 billion, a P/E ratio of 11.94, a price-to-earnings-growth ratio of 0.91 and a beta of 0.27. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping the consensus estimate of $7.88 by $0.20. The firm had revenue of $72.50 billion during the quarter, compared to analysts’ expectations of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The company’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same period last year, the company posted $6.64 EPS. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, research analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th will be issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.4%. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date is Thursday, March 5th. Cigna Group’s dividend payout ratio is currently 28.13%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.